U.S. Congressman Larry Bucshon (R-IN) says marijuana should be rescheduled under federal law to free up research that could inform the development of a regulatory framework for cannabis products. While he opposes legalization, Bucshon acknowledges the need to address THC products nationally and recognizes the limited research on its potential health effects is due to its Schedule I classification. “I mean, we’ve known the tobacco situation for decades now, so we have to maybe address that first,” said Bucshon who is a heart surgeon. “Some people are saying, well, maybe we should put THC as a S…
